Exhibit 99.1 GENMAB 2022 ANNUAL REPORT Table of Contents MANAGEMENT’S REVIEW Our Vision 2 Chair’s Statement 2 Letter from the CEO 3 2022 at a Glance 4 Consolidated Key Figures 6 2023 Outlook 9 Our Strategy 11 Who We Are 13 Business Model 14 Research and Development Capabilities 15 Enhancing Commercialization Capabilities to Bring Our Innovations to Patients 16 Antibody Discovery and Development 17 Products and Technologies 17 Corporate Social Responsibility and Sustainability Commitments 37 Genmab’s Task Fo ...